Monitoring of WT1-specific cytotoxic T-lymphocytes after allogeneic haematopoietic stem cell transplantation

被引：0
|
作者：
Morita, Y
Heike, Y
Kawakami, M
Miura, O
Mori, S
Tanosaki, R
Fukuda, T
Kim, S
Tobinai, K
Takaue, Y
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Tokyo Med & Dent Univ, Tokyo, Japan
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [21] Evaluation of cytomegalovirus-specific cytotoxic T-lymphocytes in patients with HLA-A*02 or HLA-A*24 phenotypes undergoing haematopoietic stem cell transplantation
    Morita, Y
    Heike, Y
    Hosokawa, M
    Tanosaki, R
    Mori, S
    Kim, S
    Kami, M
    Miura, O
    Tobinai, K
    Takaue, Y
    BONE MARROW TRANSPLANTATION, 2005, 35 : S27 - S27
  • [22] Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury
    Asai, Hiroaki
    Fujiwara, Hiroshi
    Kitazawa, Sohei
    Kobayashi, Naoto
    Ochi, Toshiki
    Miyazaki, Yukihiro
    Ochi, Fumihiro
    Akatsuka, Yoshiki
    Okamoto, Sachiko
    Mineno, Junichi
    Kuzushima, Kiyotaka
    Ikeda, Hiroaki
    Shiku, Hiroshi
    Yasukawa, Masaki
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7
  • [23] Myeloma cells are sensitive to granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes.
    Azuma, T
    Ohtsuki, T
    Niiya, H
    Kojima, K
    Fujita, S
    Yasukawa, M
    BLOOD, 2002, 100 (11) : 399A - 399A
  • [24] Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury
    Hiroaki Asai
    Hiroshi Fujiwara
    Sohei Kitazawa
    Naoto Kobayashi
    Toshiki Ochi
    Yukihiro Miyazaki
    Fumihiro Ochi
    Yoshiki Akatsuka
    Sachiko Okamoto
    Junichi Mineno
    Kiyotaka Kuzushima
    Hiroaki Ikeda
    Hiroshi Shiku
    Masaki Yasukawa
    Journal of Hematology & Oncology, 7
  • [25] In vitro generation of WT1-specific T-cells from healthy donors for the adoptive immunotherapy after haploidentical stem cell transplantation
    Weber, G.
    Karbach, J.
    Kuci, S.
    Willasch, A.
    Kreyenberg, H.
    Klingebiel, V
    Wels, W. S.
    Jaeger, E.
    Bader, B.
    KLINISCHE PADIATRIE, 2008, 220 (03): : 211 - 211
  • [26] Infusion of CD19-Directed and Multivirus Specific Cytotoxic T Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation for B Cell Malignancies
    Cruz, Conrad Russell Y.
    Micklethwaite, Kenneth P.
    Savoldo, Barbara
    Ku, Stephanie
    Krance, Robert A.
    Diouf, Oumar
    Kamble, Rammurti
    Barrett, A. John
    Shpall, Elizabeth J.
    Heslop, Helen E.
    Rooney, Cliona M.
    Brenner, Malcolm K.
    Bollard, Catherine M.
    Dotti, Gianpietro
    BLOOD, 2011, 118 (21) : 1743 - 1744
  • [27] Immunomonitoring of adenovirus infectious risk and of specific cytotoxic lymphocytes infusion in paediatric haematopoietic stem cell transplantation
    Guerin-El Khourouj, V.
    Dalle, J. -H.
    Pedron, B.
    Yakouben, K.
    Bensoussan, D.
    Cordeiro, D. Jorge
    Peltier, L.
    Ouachee-Chardin, M.
    Baruchel, A.
    Sterkers, G.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S208 - S209
  • [28] Transfusion requirements after allogeneic haematopoietic stem cell transplantation
    Bini-Antunes, M
    Santos, L
    Campilho, F
    Rosales, M
    Amado, F
    Campos, A
    Vaz, CP
    Pimentel, P
    Carvalhais, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S121 - S122
  • [29] Adoptive Therapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes for Refractory Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Jiang, Zhonghui
    Fan, Zhiping
    Xu, Hui
    Xu, Na
    Zhang, Tian
    Xue, Huiwen
    Lin, Ren
    Wang, Zhixiang
    Jiang, Ling
    Sun, Jing
    Xuan, Li
    BLOOD, 2023, 142
  • [30] Safety of pembrolizumab after allogeneic haematopoietic stem cell transplantation
    Yok-Lam Kwong
    Annals of Hematology, 2016, 95 : 1191 - 1192
12345